Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases Clinical Trial
— CFMOfficial title:
Effect of Anesthesia on Force Application During Colonoscopy
Verified date | July 2016 |
Source | Artann Laboratories |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The aim of the study is to determine if more force is used during colonoscopy when patients receive monitored anesthesia with propofol versus conscious sedation. Force measurements will be performed using the colonoscopy force monitor (CFM). This device measures the magnitude and direction of force applied to the insertion tube of a standard colonoscope during colonoscopy.
Status | Completed |
Enrollment | 102 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 30 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Male or female - Age: 30-75 years - ASA Class I or II - All ethnic and racial groups will be included Exclusion Criteria: - Colonic pathology that in the opinion of the endoscopist could interfere with the colonoscopy. Examples include: colonic stricture, poor preparation, obstructing tumor. - Specific pathology that would limit the extent of examination - ASA class 3 or greater - Pregnancy - Monitored anesthesia using propofol for sedation. - Vulnerable subjects. Students, nursing home residents, institutionalized patients, and those with psychological or physical incapacity |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Chevy Chase Endoscopy Center | Chevy Chase | Maryland |
United States | Univeristy of Pennsylvania Medical Center | Philadelphia | Pennsylvania |
United States | Georgetown University Medical Center, Gastroenterology | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Artann Laboratories | Capital Digestive Care, LLC, Georgetown University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Pennsylvania |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Peak push force is increased in patients receiving propofol as compared to conscious sedation. | 6 months | Yes |